InvestorsHub Logo
Followers 65
Posts 3399
Boards Moderated 0
Alias Born 07/26/2012

Re: None

Friday, 10/28/2016 10:56:34 AM

Friday, October 28, 2016 10:56:34 AM

Post# of 1084
This is very interesting, Phase II Borealis clinical trial survival result from Apatorsen Added to patients bladder cancer treatment shows a 20% reduction in death. Adding Apatorsen seem to be playing a very important part in reducing the death rate from bladder cancer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACHV News